← Back to news

Markets

Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224

Y

Here’s What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)

Y

Intellia Therapeutics (NTLA) Announces Fiscal Q4 and Full Year 2025 Financial Results

Y

Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas

Y

Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street?

Y

Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here’s Why

Y

Here’s What Analysts Are Saying About Vertex Pharmaceuticals (VRTX)

Y

Wolfe Research Initiates Coverage of UniQure (QURE) With a Peer Perform Rating

Y

Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds

Y

Novo Nordisk A/S (NVO) and Vivtex Corporation Announce a Partnership

Y

Wells Fargo Cuts PT on MetLife, Inc. (MET) to $93 From $97, Here’s Why

Y

Dell Technologies (DELL) Announces Financial Results for Fiscal Q4 2026 and Full Year Ended January 30, 2026

Y

Accenture (ACN) and Mistral AI Announce a Multi-Year Strategic Collaboration

Y

BofA Lifts PT on Apollo Global Management (APO) to $167 From $161 – Here’s Why

Y

Is Blackstone Inc. (BX) One of the Best Cheap Blue Chip Stocks to Buy According to Analysts?

Y

Adobe (ADBE) and WPP Announce Expansion of Their Long-Standing Global Partnership

Y

Intuit Inc. (INTU) Announces Financial Results for Fiscal Q2 2026

Y

Why Booking Holdings Inc. (BKNG) is One of the Best Cheap Blue Chip Stocks to Buy According to Analysts

Y

Baird Cuts PT on Salesforce, Inc. (CRM) to $250 From $315 – Here’s Why

Y

Where is UnitedHealth Group Incorporated (UNH) Headed?

Y

Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here’s Why

Y

Gray Media (GTN) Posts Q4 2025 Results, Misses Street’s Estimates

Y

Wall Street Bullish on Community Health Systems (CYH)

Y

BitFuFu Inc. (FUFU) Announced January 2026 Production Update

Y

Ribbon Communications (RBBN) Partners With Amazon Web Services, Here’s What You Should Know

Y

Rimini Street (RMNI) Posts Q4 2025 Results, Exceeds Revenue Estimates

Y

Morgan Stanley Maintains a Hold Rating on Snap Inc. (SNAP)

Y

Lufax Holding (LU) Announces Changes in Senior Management and Directors

Y

Barclays Remain a Buy on Newell Brands Inc (NWL)

Y

RBC Capital Lowers PT on Clarivate Plc (CLVT) Following Q4 2025 Results

Y

Enovis Q4 Earnings Call Highlights

Y

EOG Resources Q4 Earnings Call Highlights

Y

Silver And Gold: Short Squeeze Potential Is Still Considerable

S

Microsoft: Shares Look More Attractive As AI Reverts To Tech Growth Norm?

S

Dear Berkshire Hathaway Stock Fans, Mark Your Calendars for February 28

Y

Melrose Industries Sell-Off Looks Overdone After Strong Results

S

Perfect 10?

S

Chord Energy: This U.S. Oil Gem's Valuation Disconnect Is Too Big To Ignore

S

Green Plains Details 45Z Credit Upside, Data-Driven Plant Shift and Low-Carbon Push at Conference

Y

DoubleVerify Q4 Earnings Call Highlights

Y

Diana Shipping Q4 Earnings Call Highlights

Y

DiamondRock Hospitality Q4 Earnings Call Highlights

Y

Ginkgo Bioworks Q4 Earnings Call Highlights

Y

Dole Q4 Earnings Call Highlights

Y

Wynn Resorts (WYNN) Posts Steady Q4 Results as UAE Project Advances

Y

Cloudflare (NET) Gains Upgrade Following Strong Q4 Execution and Growth

Y

Barclays Sees Long-Term Upside in Zscaler (ZS) With Strong Revenue Retention

Y

VC ‘spray-and-pray era over’ as crypto startups raise $883m in February

Y

Netflix Backs Out of the Warner Bros. Deal. 5 Reasons It's a Smart Move

Y

Keurig Dr Pepper (KDP) Gets Price Target Increase to $32 from Barclays

Y